$MRK Merck : Domain Therapeutics receives development milestone payment from Merck KGaA, Darmstadt, Germany, for ... 
https://t.co/7jjRUYehgK
'This new adenosine receptor antagonist is one of the strategic assets in our immuno-oncology pipeline,'